Fig. 4.

Total HIV DNA during the 34-week study period in the vorinostat/hydroxychloroquine/maraviroc treatment arm (left panel) versus ART only (right panel).

Grey shaded area represents the VHM treatment period. Treatment in both arms was interrupted at week 10. The vertical dashed lines represent the minimum and maximum times following treatment interruption at which viral rebound occurred (2–7 weeks in the VHM ​+ ​ART group and 4–16 weeks in the ART only group). Horizontal bars at the top of the left panel show the timing of vorinostat administration. Horizontal dashed line shows the limit of detection of the assay. The color schema used in Fig. 2 for each participant is retained. C: Cycle.